Phase II trial of mitoxantrone in patients with primary liver cancer.
作者信息
Falkson G, Coetzer B J, Terblanche A P
出版信息
Cancer Treat Rep. 1984 Oct;68(10):1311-2.
PMID:6525607
Abstract
摘要
相似文献
1
Phase II trial of mitoxantrone in patients with primary liver cancer.米托蒽醌用于原发性肝癌患者的II期试验。
Cancer Treat Rep. 1984 Oct;68(10):1311-2.
2
Phase II trial of mitoxantrone in advanced primary liver cancer: a Cancer and Leukemia Group B Study.米托蒽醌治疗晚期原发性肝癌的II期试验：癌症与白血病B组研究
Cancer Treat Rep. 1986 Sep;70(9):1125-6.
3
Phase II trial of mitoxantrone in previously untreated patients with colorectal adenocarcinoma: A Southwest Oncology Group Study.
Cancer Treat Rep. 1982 Sep;66(9):1779-80.
4
Phase II trial of mitoxantrone in advanced colorectal cancer.米托蒽醌治疗晚期结直肠癌的II期试验。
Cancer Treat Rep. 1982 Nov;66(11):1995-6.
5
[Phase II study of mitoxantrone].米托蒽醌的II期研究
Gan To Kagaku Ryoho. 1984 Aug;11(8):1649-54.
6
Phase II trial of mitoxantrone.
Cancer Treat Rep. 1982 Nov;66(11):1929-31.
7
Phase II evaluation of mitoxantrone in advanced carcinoma of the stomach: a Southeastern Cancer Study Group Trial.
Cancer Treat Rep. 1986 Aug;70(8):1043-4.
8
Phase II evaluation of mitoxantrone in advanced renal cell carcinoma: a Southeastern Cancer Study Group Trial.米托蒽醌用于晚期肾细胞癌的II期评估：一项东南癌症研究组试验
Cancer Treat Rep. 1986 Jul;70(7):921-2.
9
Phase II trial of mitoxantrone in advanced sarcomas: a Southwest Oncology Group study.米托蒽醌治疗晚期肉瘤的II期试验：一项西南肿瘤协作组的研究。
Cancer Treat Rep. 1985 Feb;69(2):231-3.
10
Mitoxantrone: modest activity in a phase II trial in advanced prostate cancer.米托蒽醌：在晚期前列腺癌的II期试验中有适度活性。
Cancer Treat Rep. 1983 Dec;67(12):1133-5.
引用本文的文献
1
Mitoxantrone use in breast cancer patients with elevated bilirubin.米托蒽醌在胆红素升高的乳腺癌患者中的应用。
Breast Cancer Res Treat. 1989 Dec;14(3):267-74. doi: 10.1007/BF01806298.
2
Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.米托蒽醌。对其药效学和药代动力学特性以及在癌症化疗中的治疗潜力的综述。
Drugs. 1991 Mar;41(3):400-49. doi: 10.2165/00003495-199141030-00007.
Zotero 插件